Connecticut Attorney General warning about the use of non FDA approved weight loss injections, consequences ABC7 New York GLP 1 rec agonists have evolved over the past 20+ years as game changers for type 2 diabetes to highly effective medications for the treatment of obesity by targeting the neurometabolic pathophysiology of obesity Saxenda vs. Victoza: Differences and Similarities Ro Foundayo vs. Wegovy: How Do the New Weight Loss Pills Compare? SELF